Wearable Medical Devices 2024 Industry Size, Status, Analysis and Forecast 2030

 

Wearable Medical Devices Industry Overview

The global wearable medical devices market size was estimated at USD 33.85 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 25.66% from 2024 to 2030.

The anticipated growth in industries like remote patient monitoring and home healthcare will impact the market, along with an increased focus on fitness and a health-oriented lifestyle. The market holds significant opportunities driven by technological advancements, merger and acquisition activities, increasing clinical trials, and heightened awareness of personal health monitoring.

Due to sedentary routines, lifestyle-related disorders like diabetes and hypertension are expected to rise, necessitating continuous monitoring of physiological parameters. Portable medical devices enable the amalgamation of healthcare data, providing real-time access for physicians and minimizing errors. The increasing mortality rate from non-communicable diseases emphasizes the need for personalized monitoring and care, contributing to an increased demand for wearable medical products.

Gather more insights about the market drivers, restrains and growth of the Wearable Medical Devices Market

The COVID-19 pandemic has expanded the utility of wearable medical devices in healthcare. Innovative products, like the Ava Bracelet, initially designed as a fertility tracker, are now repurposed to detect early signs of viral infections. With monitoring parameters such as heart rate variability, breathing rate, and skin temperature, the bracelet proves valuable in tracking COVID-19 symptoms, presenting a distinctive opportunity during the global health crisis.

The escalating prevalence of chronic diseases and rising mortality rates are causing major concern, prompting healthcare providers to focus on personalized care, particularly through continuous remote patient monitoring. Wearable medical devices, capable of 24-hour wear without disrupting daily routines, are gaining traction due to their various advantages. Consequently, the demand for these devices is expected to surge over the forecast period.

Wearable medical devices are playing a pivotal role in the cardiovascular device market. These innovative technologies, ranging from smartwatches to continuous monitoring devices, offer new avenues for real-time health tracking, early detection of cardiovascular issues, and personalized patient care. The integration of wearable devices in cardiovascular healthcare reflects a transformative shift towards preventive and proactive healthcare solutions, ultimately enhancing patient outcomes and disease management.

Browse through Grand View Research's Medical Devices Industry Research Reports.

• The global cardiac safety services market size was estimated at USD 870.48 million in 2023 and is projected to grow at a CAGR of 12.0% from 2024 to 2030.

• The China blood pressure monitoring devices market size was estimated at USD 438.0 million in 2023 and is projected to grow at a CAGR of 13.0%, from 2024 to 2030.

Key Companies & Market Share Insights

By introducing groundbreaking technologies, key wearable medical device companies are significantly impacting the market. Innovations such as advanced wearable medical device sensors, continuous monitoring capabilities, and integration with artificial intelligence are reshaping the landscape. Industry leaders leverage these technologies to enhance the accuracy and range of health metrics that wearable devices can track. Moreover, the incorporation of data analytics and cloud connectivity enables seamless data sharing, improving the overall healthcare ecosystem. This technological evolution propels the market's growth. It contributes to improved patient outcomes, personalized healthcare, and the transformation of wearable medical devices into indispensable tools for consumers and healthcare providers.

Key Wearable Medical Devices Companies:

The following are the leading companies in the wearable medical devices market. These companies collectively hold the largest market share and dictate industry trends. Financials, strategy maps & products of these wearable medical devices companies are analyzed to map the supply network

·         Koninklijke Philips N.V.

·         Fitbit

·         Basis Science

·         Garmin

·         Covidien (Medtronic)

·         Omron Corp.

·         Withings

·         Vital Connect

·         Polar Electro

·         Everist Genomics

·         Intelesens Ltd.

·         Sotera Wireless

·         Apple

Recent Developments

In January 2024,Sennheiser collaborated with Polar Electro to launch the Momentum Sport earbuds, marking the first time Polar's bio-sensing capabilities extend beyond its products. These German-engineered earbuds deliver high-quality sound and integrate Polar's fitness technology, incorporating features such as a body temperature sensor and a Photoplethysmography (PPG) heart rate sensor for monitoring hydration levels during workouts. Users can access the comprehensive data analytics ecosystem through the Polar Flow training app, which offers expert-tier performance tracking, training analytics, voice guidance, and smart coaching. This collaboration is poised to impact the wearable medical devices market by expanding bio-sensing capabilities into audio devices for enhanced fitness monitoring and guidance.

In January 2024, Garmin unveiled the Lily 2 series, representing the next evolution of its petite and stylish smartwatches and introducing enhanced health, wellness, and connectivity features. The Lily 2 and Lily 2 Classic models boast an advanced redesign, featuring metal watch cases, concealed displays with distinctive patterned lenses, and a range of fashionable color options. With a substantial battery life of up to five days in smartwatch mode, users can delve into new functionalities such as sleep score tracking, dance fitness activities, and Garmin Pay contactless payments. This announcement is expected to impact the wearable medical devices market by introducing refined and fashionable smartwatches with advanced health and wellness features.

In January  2024, Garmin unveiled significant enhancements to its Garmin Connect app and website, aiming to deliver a more streamlined and personalized homepage experience centered around health and fitness metrics for users to monitor their individual goals. Specific customers utilizing Garmin smartwatches, cycling computers, and accessories can participate in the beta version of Garmin Connect, with wider availability anticipated later this year. This update is poised to impact the wearable medical devices market by offering users a more user-friendly platform focused on health and fitness tracking, enhancing the overall wearable device experience.

In June 2023, Google introduced its latest Feature Drop, incorporating a series of updates for Fitbit devices. Notable additions include a variety of exercise modes in the Exercise menu for Luxe, Charge 5, and Inspire 3, a menstrual health tile for period tracking and cycle state viewing for Versa 4 and Sense 2, and the inclusion of a Daily Readiness Score, providing insights into whether the body requires rest or a workout, accessible across all Fitbit devices. This development is anticipated to impact the wearable medical devices market by enhancing the functionality and features of Fitbit devices, catering to a broader range of user health and wellness needs.

In January 2023, Masimo and Royal Philips broadened their collaboration, utilizing the Masimo W1 advanced health tracking watch to enhance patient monitoring in the realm of home telehealth. The integration of Philips's enterprise patient monitoring ecosystem with the W1 watch is set to propel advancements in telehealth and telemonitoring capabilities. This expansion is poised to impact the wearable medical devices market by fostering innovative solutions for remote patient monitoring and enhancing the synergy between health-tracking wearables and telehealth systems.

In April 2023, Garmin revealed an extended regional availability of the Dexcom Connect IQ apps, catering to consumers managing Type 1 or Type 2 diabetes with the Dexcom G6 or Dexcom G7 Continuous Glucose Monitoring System. These applications empower users to conveniently monitor their glucose levels and trends directly on a compatible smartwatch or cycling computer. This announcement is expected to impact the wearable medical devices market by providing enhanced accessibility to glucose monitoring solutions for individuals with diabetes, further integrating health monitoring into daily wearable technology.

Order a free sample PDF of the Wearable Medical Devices Market Intelligence Study, published by Grand View Research.